Connecting the Dots: Gender, Sexuality, and Societal Influences on Cognitive Aging and Alzheimer's Disease
- PMID: 38899350
- DOI: 10.2174/0118746098299754240530111755
Connecting the Dots: Gender, Sexuality, and Societal Influences on Cognitive Aging and Alzheimer's Disease
Abstract
Alzheimer's disease (AD) has many etiologies and the impact of gender on AD changes throughout time. As a consequence of advancements in precision medical procedures and methodology, Alzheimer's disease is now better understood and treated. Several risk factors may be addressed to lower one's chances of developing Alzheimer's disease or associated dementia (ADRD). The presence of amyloid-α protein senile plaques, intracellular tau protein neurofibrillary tangles (NfTs), neurodegeneration, and neuropsychiatric symptoms (NPS) characterizes Alzheimer's disease. NPS is common in persons with Alzheimer's disease dementia, although its presentation varies widely. Gender differences might explain this clinical variability. The fundamental goal of this review is to 1) emphasize the function of old age, sex, and gender in the development of Alzheimer's disease, dementia, and ADRD, and 2) explain the importance of sexual hormones, education, and APOE (Apolipoprotein E) status. This is a narrative summary of new ideas and concepts on the differences in the chance of developing dementia or Alzheimer's disease between men and women. A more thorough examination of risk and protective variables in both men and women might hasten research into the epidemiology of neurological illnesses such as dementia and Alzheimer's disease. Similarly, future preventive efforts should target men and women separately.
Keywords: ADRD; APOE.; Alzheimer’s; dementia; gender; neuropsychiatric; sexual hormones.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.Arch Neurol. 1998 Mar;55(3):326-35. doi: 10.1001/archneur.55.3.326. Arch Neurol. 1998. PMID: 9520006
-
Sex and gender differences in the causes of dementia: a narrative review.Maturitas. 2014 Oct;79(2):196-201. doi: 10.1016/j.maturitas.2014.05.008. Epub 2014 May 27. Maturitas. 2014. PMID: 24954700 Free PMC article. Review.
-
Prospective Associations between Single Foods, Alzheimer's Dementia and Memory Decline in the Elderly.Nutrients. 2018 Jun 29;10(7):852. doi: 10.3390/nu10070852. Nutrients. 2018. PMID: 29966314 Free PMC article.
-
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.J Neurol Neurosurg Psychiatry. 1996 Oct;61(4):352-6. doi: 10.1136/jnnp.61.4.352. J Neurol Neurosurg Psychiatry. 1996. PMID: 8890772 Free PMC article.
-
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.Ageing Res Rev. 2012 Jan;11(1):87-103. doi: 10.1016/j.arr.2011.06.005. Epub 2011 Jul 7. Ageing Res Rev. 2012. PMID: 21763789 Review.
Cited by
-
Trend analysis and future predictions of global burden of alzheimer's disease and other dementias: a study based on the global burden of disease database from 1990 to 2021.BMC Med. 2025 Jul 1;23(1):378. doi: 10.1186/s12916-025-04169-w. BMC Med. 2025. PMID: 40597083 Free PMC article.
References
-
- Association A.; 2021 Alzheimer's disease facts and figures. Alzheimers Dement 2021,17(3),327-406 - DOI
-
- Prince M.J.; Wimo A.; Guerchet M.M.; Ali G.C.; Wu Y-T.; Prina M.; The global impact of dementia: An analysis of prevalence, incidence, cost and trends. Alzheimer’s Dis Int 2015,84,1-26
-
- Matthews F.E.; Stephan B.C.M.; Robinson L.; Jagger C.; Barnes L.E.; Arthur A.; Brayne C.; Comas-Herrera A.; Wittenberg R.; Dening T.; McCracken C.F.M.; Moody C.; Parry B.; Green E.; Barnes R.; Warwick J.; Gao L.; Mattison A.; Baldwin C.; Harrison S.; Woods B.; McKeith I.G.; Ince P.G.; Wharton S.B.; Forster G.; A two decade dementia incidence comparison from the cognitive function and ageing studies I and II. Nat Commun 2016,7(1),11398 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous